Join us for the 20th Anniversary of the annual EMBL PhD Symposium. Since its
conception in 1999, the EMBL PhD Symposium has evolved into a highly respected
scientific meeting, connecting young researchers and high-profile scientists
alike. This year, we invite you to celebrate revolutionary ideas in molecular life sciences
and explore the game-changing ideas that are shaping the face of modern science.
Over the last decade, we have seen many breakthroughs in the life sciences, much of these the consequence of collaborative, multi-disciplinary research. This year’s annual symposium will celebrate some of these breakthroughs, and share and discuss the up-and-coming ideas in science. We have an exciting line up of speakers confirmed from Nobel Laureate Professor Stefan W. Hell, to celebrated author Professor Nick Lane, to project leader of the ATLAS Detector Experiment at CERN, Professor Pippa Wells.
The meeting aims to showcase exciting and groundbreaking research, from Master's projects all the way to Nobel Prize winning work. It is an opportunity to meet the game changers in modern science and to network with the next generation of scientists. With a broad theme, we hope to encourage many young researchers from across the sciences to showcase their research, stimulate cross-disciplinary discussion and meet scientists from diverse backgrounds to share ideas.
Come and join us at the 20th EMBL PhD Symposium, for three days of exciting and game-changing science.
Max Planck Institute for Biophysical Chemistry & Max Planck Institute for Medical Research - Germany
Stefan W. Hell is a director at the Max Planck Institute for Biophysical Chemistry in Göttingen and at the Max Planck Institute for Medical Research in Heidelberg. He is credited with having conceived, validated and applied the first viable concept for breaking Abbe’s diffraction-limited resolution barrier in a light-focusing microscope. He has received several awards for his game changing work, including the 2014 Kavli Prize in Nanoscience and the Nobel Prize in Chemistry.
Institut du Cerveau et de la Moelle épinière – ICM (Brain & Spine Institute) - France
Claire Wyart is a group leader at the Brain and Spinal Cord Institute (ICM). She is developing methods for monitoring and manipulating neuronal activity in the zebrafish larva to study the integration of information from the brain, the periphery and the internal cues into neuronal circuits that modulate locomotion and posture as a function of our inner physiological states. Claire is the recipient of a number of prestigious awards and prizes, including the 2016 New York Stem Cell Foundation Robertson Innovation in Neuroscience Award and the 2017 Young Investigator Award from the European Molecular Biology Organisation.
European Bioinformatics Institute (EMBL-EBI) - UK
Ewan Birney is Director of EMBL-EBI (together with Dr Rolf Apweiler) and a Fellow of the Royal Society. He played a vital role in annotating the genome sequences of human, mouse and several other organisms and led the analysis group for the ENCODE project. He has received a number of prestigious awards for his work including the 2003 Francis Crick Award from the Royal Society. Ewan is also a consultant and advisor to a number of companies including Oxford Nanopore Technologies.
University College London - UK
Nick Lane is Professor of Evolutionary Biochemistry in the Department of Genetics, Evolution and Environment at University College London. Professor Lane predominantly works to investigate how energy flow has shaped evolution over four billion years, using a mixture of theoretical and experimental work to address the origin of life, the evolution of complex cells and downright peculiar behaviour such as sex. He was a founding member of the UCL Consortium for Mitochondrial Research, and is Co-Director of the UCL Centre for Life’s Origin and Evolution (CLOE). He has received numerous awards, including the 2016 Royal Society Michael Faraday Prize and Lecture, the UK’s premier award for excellence in communicating science. Professor Lane has written four celebrated books for the general public, which have been translated into 30 languages.
Wellcome Sanger Institute - UK
Sarah Teichmann is Head of Cellular Genetics at the Wellcome Sanger Institute, and co-chair of the Human Cell Atlas Consortium. Her research focuses on deciphering the immune system with genomics and bioinformatics approaches on the single cell level. Sarah is also a Director of Research in the Cavendish Laboratory, University of Cambridge and Senior Research Fellow at Churchill College. Her work has been recognised by a number of international awards including the Lister Prize and the Biochemical Society Colworth Medal.
LPTMS, CNRS & University Paris-Sud - France
Martin Lenz is a group leader at the National Center for Scientific Research (CNRS) and Université Paris-Sud. By producing robust theoretical results insensitive to unknown molecular detail, he aims to understand the non-equilibrium mechanisms responsible for the dynamics of the cytoskeleton and the mechanics of protein-induced cell membrane remodelling. Martin has received a number of prestigious awards for his work including the 2016 Young Investigator Award from European Molecular Biology Organisation.
MRC Cancer Unit, University of Cambridge - UK
Rebecca Fitzgerald is Professor of Cancer Prevention at the University of Cambridge. Rebecca continues to practice medicine and is an Honorary Consultant in Gastroenterology, Addenbrooke’s Hospital Cambridge. The focus of her research is to improve methods for early detection of oesophageal cancer through better understanding of the molecular pathogenesis. Rebecca was awarded the prestigious Westminster medal and prize for her first proof of concept work on the Cytosponge™ and associated assays for diagnosing Barrett’s oesophagus in 2004. Rebecca is committed to bringing research advances into clinical practice and inspiring other researchers to do likewise.
CamBioScience & University of Cambridge - UK
Chibeza Chintu Agley is the founder CEO of the start-up software company CamBioScience Limited and a Fellow of Homerton College, University of Cambridge. CamBioScience has built a cloud learning platform that combines cutting-edge and internationally sourced content with custom-built Artificial Intelligence and Augmented Video Reality technology to meet the demands of the rapidly advancing fields of science and technology. Chibeza Agley has received several research awards prior to founding CamBioScience, including the Colt Foundation Prize for Best Research Project and the Tadien Rideal Prize for outstanding doctoral research in molecular science.
European Molecular Biology Laboratory (EMBL), Heidelberg - Germany
Julia Mahamid is a group leader in the Structural and Computational Biology Unit of the European Molecular Biology Laboratory. Her research primarily uses cellular cryo-electron tomography to provide a structural understanding of fundamental questions in cell biology. In recognition of her work, Julia has received multiple awards, including the MPIB Junior Research Award from the Max Planck Institute of Biochemistry (MPIB) and the European Microscopy Society (EMS) Outstanding Paper Award.
iThinkWell & Flinders University - Australia
Hugh Kearns is recognised internationally as a public speaker, educator and researcher. He regularly lectures at leading universities across the world. His areas of expertise include self-management, positive psychology, work-life balance, learning and creativity. He draws on over twenty five years of experience as a leading training and development professional within the corporate, financial, education and health sectors in Ireland, Scotland, North America, New Zealand and Australia. Hugh lectures and researches at Flinders University, Adelaide, Australia. He is widely recognised for his ability to take the latest research in psychology and education and apply it to high-performing people and groups.
European Organization for Nuclear Research (CERN) - Switzerland
Pippa Wells is an ATLAS experimental particle physicist and the Head of Member State Relations at the European Organisation for Nuclear Research (CERN). After completing her doctorate at the University of Cambridge, Dr Wells joined CERN as a fellow to work on the OPAL experiment at the LEP collider. She subsequently joined the ATLAS experiment at the Large Hadron Collider. For a number of years, she was project leader of the inner tracking detector, which measures charged particles as they emerge from the interaction point, and which played a crucial role in the discovery of the Higgs boson in 2012. More recently, she led the studies to demonstrate the physics potential of a high-luminosity upgrade of the LHC. In 2016, she took on the role of Head of Member State Relations at CERN.
College of Medicine, University of Ibadan - Nigeria
Dr Amos Olalekan Abolaji is a Senior Lecturer in the Department of Biochemistry, University of Ibadan, Nigeria, researching the mechanisms by which environmental toxins contribute to the pathogenesis of neurodegenerative diseases and female reproductive dysfunctions. Since 2014, as a DrosAfrica trust collaborator, he has been training selected African researchers on the use of D. melanogaster in biomedical research, and has freely distributed different strains of flies to their institutions. Dr Abolaji is a recipient of several awards including CNPq-TWAS Postdoctoral Fellowship and a member of Society of Toxicology, Society For Redox Biology and Medicine, and European Teratology Society.
Francis Crick Institute & Imperial College London - UK
George Kassiotis is currently a Senior Group Leader and head of the laboratory of Retroviral Immunology at the Francis Crick Institute, London, UK. He is also a Professor of Retrovirology, at the Department of Medicine, Imperial College London, UK, and recipient of a New Investigator Award from the Wellcome Trust, UK. His laboratory's work concentrates on innate and adaptive immune responses to endogenous and exogenous retroviruses, as well as the broader evolutionary impact of endogenous retro-elements on the development and function of host immunity.
Heidelberg is easily reached by train, car or plane from any country in the world. The EMBL campus is located in the neighbourhood area of Boxberg which is approximately 10 minutes by car from Heidelberg's city centre.Reaching us by train, plane, or car.
Prior to travelling to Germany, some applicants from certain countries may have to acquire special travel documents, such as a visa. Applicants are strongly encouraged to check with the local German Authorities (Embassies or Consulates) about the need for special travelling documents. Since the process may be time consuming, applicants are advised to make such arrangements as soon as possible. Failure to obtain a visa after the deadline for participation in the conference will not result in a refund. Applicants are responsible for providing the right documentation needed for their entry into Germany. However, upon request, the Organising Committee can issue a formal letter of acceptance to the symposium for the purposes of obtaining a visa. Please be aware that no visa letters will be issued before payment of the registration fee. The organising committee can not be held responsible in the case of a refusal by German authorities to enter German territory.
The registration fee does not include accommodation, which has to be personally arranged. However, we have reserved a number of rooms at the EMBL/ISG Hotel available for conference participants to book if desired. The Hotel offers twin rooms, at a cost of 51 EUR per person/per night incl. breakfast when shared with another participant, and 78 EUR per person/per night incl. breakfast in a personal twin room. Please indicate when you are making the booking if you would like to book a shared or personal twin room and if there is a particular participant with whom you would like to share.
Please call or email the ISG Hotel for your booking and use the code “PhD Symposium 2018” to receive the EMBL special rate.
A shuttle bus will run between EMBL and the ISG Hotel during the conference.
Concerned about funding? We want to help you come to Heidelberg and this year we will be offering more travel grants than ever before. See below for details of current grants available.
Below you can find a list of travel or support grants:
Please note that you need to apply independently to these grants.
If you require any assistance please do not hesitate to contact the Symposium Organisers.
Concerned about funding? We want to help you come to Heidelberg! There are three ways to apply for a travel grant:
|Registration:||September 7th||October 5th|
|Abstract submission:||October 5th|
Please follow the appropriate link below to register for the Symposium. If you have not registered for an EMBL event before, you will have to make a new account before registering.
|General (Early Bird)||150€||Register|
|Industry (Early Bird)||200€||Register|
|EMBL Staff (including new EMBL PhD Students)||Register|
Please note, payment is by credit card only. If you experience any issues with payment, please contact the Symposium Organisers.
The Symposium offers the opportunity to present your work to an international
audience. There are a number of slots reserved for talks from participants,
and two poster sessions for participants to present their work. Last year
we received submissions on a range of topics, including Bachelor’s theses,
Master’s Projects and PhD work.
We encourage all participants to submit an abstract: all those who do have the opportunity to present their work as a scientific poster. If you would also like to be considered for a talk, please indicate this when submitting your abstract. You will be notified if you have been selected to give a talk in due course.
Together with the GBM, the two best posters will be awarded with the GBM Poster Prize (150€ each prize) on the last day of the conference.
To receive updates about the Symposium subscribe below.
The EMBL PhD symposium will provide an invaluable networking environment for your company to enhance the profile amongst the molecular biosciences research community, especially towards the young generation. The symposium will offer prime opportunities for your company to promote your new products, latest technology, and services. If you are interested in sponsoring our symposium and would like to have more information, direct your enquires to us.